Charles Y Lin Kronos Bio, Inc. (KRON) insider trading activity

KRON Quotes by TradingView

Charles Y Lin is Chief Scientific Officer of Kronos Bio, Inc.. Currently has a direct ownership of 234,603 shares of KRON, which is worth approximately $192,374. The most recent transaction as insider was on Feb 21, 2024, when has been sold 12,036 shares (Common Stock) at a price of $1.05 per share, resulting in proceeds of $12,637. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 235K
0% 3M change
0% 12M change
Total Value Held $192,374

Charles Y Lin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2024
SELL
Open market or private sale
$12,637 $1.05 p/Share
12,036 Reduced 4.88%
234,603 Common Stock
CYL

Charles Y Lin

Chief Scientific Officer
San Mateo, CA

Track Institutional and Insider Activities on KRON

Follow Kronos Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if
Any

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Kronos Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRON